Your browser doesn't support javascript.
loading
Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression.
Garcia, Alejandro J; Ruscetti, Marcus; Arenzana, Teresita L; Tran, Linh M; Bianci-Frias, Daniella; Sybert, Elysia; Priceman, Saul J; Wu, Lily; Nelson, Peter S; Smale, Stephen T; Wu, Hong.
Afiliación
  • Garcia AJ; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Ruscetti M; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA
  • Arenzana TL; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Tran LM; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Bianci-Frias D; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Sybert E; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Priceman SJ; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Wu L; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Smale ST; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
  • Wu H; Department of Molecular and Medical Pharmacology, Institute for Molecular Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. School of Life Sciences, PKU-Tsinghua Center for Life Sciences, Peking University, Beijing, China
Mol Cell Biol ; 34(11): 2017-28, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24662052
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfohidrolasa PTEN / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Cell Biol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfohidrolasa PTEN / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Cell Biol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos